|
1
|
Llovet JM, Schwartz M and Mazzaferro V:
Resection and liver transplantation for hepatocellular carcinoma.
Semin Liver Dis. 25:181–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thuluvath PJ: Vascular invasion is the
most important predictor of survival in HCC, but how do we find it?
J Clin Gastroenterol. 43:101–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Bru C and Bruix J: Prognosis of
hepatocellular carcinoma: The BCLC staging classification. Semin
Liver Dis. 19:329–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng ZW, Guo RP, Zhang YJ, Lin XJ, Chen MS
and Lau WY: Hepatic resection versus transcatheter arterial
chemoembolization for the treatment of hepatocellular carcinoma
with portal vein tumor thrombus. Cancer. 118:4725–4736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park YK, Song SK, Kim BW, Park SK, Chung
CW and Wang HJ: Prognostic significance of microvascular invasion
in tumor stage for hepatocellular carcinoma. World J Surg Oncol.
15:2252017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shirabe K, Toshima T, Kimura K, Yamashita
Y, Ikeda T, Ikegami T, Yoshizumi T, Abe K, Aishima S and Maehara Y:
New scoring system for prediction of microvascular invasion in
patients with hepatocellular carcinoma. Liver Int. 34:937–941.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie
H, Liu Z, Xu Z, Wei J, Huang X and Zheng S: MicroRNA-30a-3p
inhibits tumor proliferation, invasiveness and metastasis and is
downregulated in hepatocellular carcinoma. Eur J Surg Oncol.
40:1586–1594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dang Z, Shangguan J, Zhang C, Hu P, Ren Y,
Lv Z, Xiang H and Wang X: Loss of protocadherin-17 (PCDH-17)
promotes metastasis and invasion through hyperactivation of
EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma. Tumour
Biol. 37:2527–2535. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Calvisi DF, Ladu S, Gorden A, Farina M,
Conner EA, Lee JS, Factor VM and Thorgeirsson SS: Ubiquitous
activation of Ras and Jak/Stat pathways in human HCC.
Gastroenterol. 130:1117–1128. 2006. View Article : Google Scholar
|
|
10
|
Bacigalupo ML, Manzi M, Espelt MV,
Gentilini LD, Compagno D, Laderach DJ, Wolfenstein-Todel C,
Rabinovich GA and Troncoso MF: Galectin-1 triggers
epithelial-mesenchymal transition in human hepatocellular carcinoma
cells. J Cell Physiol. 230:1298–1309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang CH, Guo ZY, Chen ZT, Zhi XT, Li DK,
Dong ZR, Chen ZQ, Hu SY and Li T: TMPRSS4 facilitates
epithelial-mesenchymal transition of hepatocellular carcinoma and
is a predictive marker for poor prognosis of patients after
curative resection. Sci Rep. 5:123662015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li PF, Chen SC, Xia T, Jiang XM, Shao YF,
Xiao BX and Guo JM: Non-coding RNAs and gastric cancer. World J
Gastroenterol. 20:5411–5419. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Liu Y, Guo Y, Liu B, Zhao Y, Li P,
Song F, Zheng H, Yu J, Song T, et al: Regulatory MiR-148a-ACVR1/BMP
circuit defines a cancer stem cell-like aggressive subtype of
hepatocellular carcinoma. Hepatology. 61:574–584. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Love MI, Huber W and Anders S: Moderated
estimation of fold change and dispersion for RNA-seq data with
DESeq2. Genome Biol. 15:5502014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
R Core Team, . R: A language and
environment for statistical computingR Foundation for Statistical
Computing; Vienna: 2016, https://www.R-project.org/April 1–2018
|
|
16
|
Dweep H and Gretz N: MiRWalk2.0: A
comprehensive atlas of microRNA-target interactions. Nat Methods.
12:6972015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Baker S, Ali I, Silins I, Pyysalo S, Guo
Y, Hogberg J, Stenius U and Korhonen A: Cancer hallmarks analytics
tool (CHAT): A text mining approach to organize and evaluate
scientific literature on cancer. Bioinformatics. 33:3973–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang F, Chang RM, Yu L, Lei X, Xiao S,
Yang H and Yang LY: MicroRNA-188-5p suppresses tumor cell
proliferation and metastasis by directly targeting FGF5 in
hepatocellular carcinoma. J Hepatol. 63:874–885. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi Y, Song Q, Yu S, Hu D and Zhuang X:
Microvascular invasion in hepatocellular carcinoma overexpression
promotes cell proliferation and inhibits cell apoptosis of
hepatocellular carcinoma via inhibiting miR-199a expression. Onco
Targets Ther. 8:2303–2310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rodríguez-Perálvarez M, Luong TV, Andreana
L, Meyer T, Dhillon AP and Burroughs AK: A systematic review of
microvascular invasion in hepatocellular carcinoma: Diagnostic and
prognostic variability. Ann Surg Oncol. 20:325–339. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park YK, Song SK, Kim BW, Park SK, Lee JI,
Lim SS and Wang HJ: Conditional survival analysis demonstrates that
recurrence risk of surgically treated hepatocellular carcinoma
evolves with time. J Gastrointest Surg. 21:1237–1244. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clavien PA, Lesurtel M, Bossuyt PM, Gores
GJ, Langer B and Perrier A; OLT for HCCConsensus Group, : OLT for
HCC consensus group. Recommendations for liver transplantation for
hepatocellular carcinoma: An international consensus conference
report. Lancet Oncol. 13:e11–e22. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bai T, Chen J, Xie ZB, Wu FX, Wang SD, Liu
JJ and Li LQ: The efficacy and safety of postoperative adjuvant
transarterial embolization and radiotherapy in hepatocellular
carcinoma patients with portal vein tumor thrombus. Onco Targets
Ther. 9:3841–3848. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo HB, Zhang Y and Chen HL: Relationship
between metastasis-associated phenotypes and N-glycan structure of
surface glycoproteins in human hepatocarcinoma cells. J Cancer Res
Clin Oncol. 127:231–236. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu X, Zhao Y, Wei L, Zhu B, Song D, Wang
J, Yu L and Wu J: CCDC178 promotes hepatocellular carcinoma
metastasis through modulation of anoikis. Oncogene. 36:4047–4059.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Budhu A, Jia HL, Forgues M, Liu CG,
Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iyengar BR, Choudhary A, Sarangdhar MA,
Venkatesh KV, Gadgil CJ and Pillai B: Non-coding RNA interact to
regulate neuronal development and function. Front cell Neurosci.
8:472014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Filipowicz W, Jaskiewicz L, Kolb FA and
Pillai RS: Post-transcriptional gene silencing by siRNAs and
miRNAs. Curr Opin Struct Biol. 15:331–341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cora D, Re A, Caselle M and Bussolino F:
MicroRNA-mediated regulatory circuits: Outlok and perspectives.
Phys Biol. 14:0450012017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ding L, Yu LL, Han N and Zhang BT: MiR-141
promotes colon cancer cell proliferation by inhibiting MAP2K4.
Oncol Lett. 13:1665–1671. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Zhou J, Sun M, Sun G, Cao Y,
Zhang H, Tian R, Zhou L, Duan L, Chen X and Lun L: Prognostic value
of microRNA-9 in various cancers: A meta-analysis. Pathol Oncol
Res. 23:573–582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang L, Cai J, Chen B, Wu S, Li R, Xu X,
Yang Y, Guan H, Zhu X, Zhang L, et al: Aberrantly expressed
miR-582-3p maintains lung cancer stem cell-like traits by
activating Wnt/beta-catenin signalling. Nat Commun. 6:86402015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He D, Wang J, Zhang C, Shan B, Deng X, Li
B, Zhou Y, Chen W, Hong J, Gao Y, et al: Down-regulation of
miR-675-5p contributes to tumor progression and development by
targeting pro-tumorigenic GPR55 in non-small cell lung cancer. Mol
Cancer. 14:732015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ma L, Tian X, Guo H, Zhang Z, Du C, Wang
F, Xie X, Gao H, Zhuang Y, Kornmann M, et al: Long noncoding RNA
H19 derived miR-675 regulates cell proliferation by down-regulating
E2F-1 in human pancreatic ductal adenocarcinoma. J Cancer.
9:389–399. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi Y, Wang Y, Luan W, Wang P, Tao T,
Zhang J, Qian J, Liu N and You Y: Long non-coding RNA H19 promotes
glioma cell invasion by deriving miR-675. PLoS One. 9:e862952014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zheng Y, Lu X, Xu L, Chen Z, Li Q and Yuan
J: MicroRNA-675 promotes glioma cell proliferation and motility by
negatively regulating retinoblastoma 1. Hum Pathol. 69:63–71. 2017.
View Article : Google Scholar : PubMed/NCBI
|
